by Neoteryx | 7 min read
The media frenzy surrounding the 2021 fraud trial of Elizabeth Holmes, the disgraced founder and CEO of blood-testing startup Theranos, has drawn the world’s attention. The Theranos story will gain …
Read Storyby Neoteryx | 4 min read
Research scientists and clinical trial managers can take advantage of the technologies that doctors are using in telemedicine to access patients at home. Shipping remote specimen collection kits out to …
Read Storyby Neoteryx | 4 min read
If you are a researcher seeking to learn more about microsampling and how it works, you can find many resources to help you on the Neoteryx website. Are you wondering …
Read Storyby Neoteryx | 4 min read
Blood sampling is an invaluable part of clinical research, but blood collection methods and blood storage chains are resource-intensive and sometimes wasteful. Most traditional blood collection methods require in-patient visits …
Read Storyby Neoteryx | 4 min read
The COVID-19 pandemic is lingering a little longer than we expected. The pandemic has dramatically impacted health institutions and other organizations, requiring them to restructure and redefine their practices in …
Read Storyby Neoteryx | 3 min read
A growing need for patients to take a more proactive role in their health has led to recent trends in "patient-centric medicine" and "telehealth." Healthcare providers who need to monitor …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.